11/23/2022Hainan Issues New Policy to Improve Drug Import Process

11/23/2022Nona Biosciences Enters into HCAb Based Drug Discovery Partnership wit...

11/23/2022Umoja Biopharma and IASO Biotherapeutics Enter Partership for Off-the-...

11/22/2022Measures for Supervision and Administration of Online Sales of Drugs: ...

11/22/2022Legal Considerations for International Licensors and Licensees Conduct...

11/21/2022Biotech CEO Interview: Harbour BioMed's Wang On Moderna Deal, New Subs...

11/21/2022Performance of A Share-listed MedPharm Cos Improved in Q3/2022

11/21/2022CDE Solicits Comments on the Technical Guidelines for Clinical Trials ...

11/21/2022CDE Solicits Comments on the Technical Guidelines for Clinical Protoco...

11/21/2022CDE Solicits Comments on the Technical Guidelines for Clinical Trials ...

11/18/2022CDE, Hainan Provincial Drug Admin Jointly Issue the Implementation Rul...

11/18/2022Recent Executive Moves

11/18/2022Drug R&D and Product Registration News Digest November 2022 (3)

11/17/2022CDE Solicits Comments on the Technical Guidelines for Clinical Researc...

11/17/2022Mirati Therapeutics Sues China's InventisBio for CNY 99M in Trade Sec...

11/17/2022Marinus Pharma and Tenacia Biotech Tie Up for Ganaxolone Development ...

11/17/2022IPF Presents Big Opportunities and Challenges for China Drugmakers

11/17/2022Growing Pains: Charting The Rapid Rise Of Chinese IO (In Vivo - Pharma...

11/16/2022Kinarus Therapeutics Engages Great Health Companion Group to Explore P...

11/16/2022CDE Solicits Comments on the Technical Guidelines for Clinical Trials ...

11/16/2022CDE Solicits Comments on the Technical Guidelines for Clinical Trials ...

11/16/2022NHC Reorganizes Medical Administration Departments to Emphasize Epidem...

11/16/2022Harbour Biomed Launches Nona Biosciences to Provide "Ideas to IND" Pre...

11/16/2022CDE Issues the Measures for Suspension and Resumption of Review Timing...

11/15/2022NMPA Holds Conference on Promotion of Foreign Trade and Investment

11/15/2022Biotheus and Hansoh Strike Licensing Deal for its EGFR/MET Bispecific ...

11/15/2022Simcere and Idorsia Enter into a Licensing Agreement for Daridorexant ...

11/15/2022WuXi Vaccines Buys Harbour BioMed China Facility

11/15/2022Highlights on the New Drug Recall Regulation of 2022 (Mondaq)

11/14/2022Fire Sale! China's "Warren Buffett" Races To Sell Assets (Forbes)

Page:65/719 Total number of articles:21546: [First][<<] [63] [64] [65] [66] [67] [>>] [End]